C G M Kallenberg Selected Research

Granulomatosis with Polyangiitis (Wegener's Granulomatosis)

1/2017	Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.
6/2015	Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
9/2013	Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.
5/2009	Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
1/2009	New advances in the pathogenesis of ANCA-associated vasculitides.
1/2009	Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
2/2008	Pathogenesis of PR3-ANCA associated vasculitis.
9/2004	B cell epitope specificity in ANCA-associated vasculitis: does it matter?
7/2004	Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
6/2003	Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C G M Kallenberg Research Topics

Disease

18	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2017 - 07/2002
14	Vasculitis (Vasculitides) 06/2015 - 07/2002
13	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2013 - 01/2002
12	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2017 - 06/2002
10	Inflammation (Inflammations) 05/2013 - 05/2008
6	Microscopic Polyangiitis 01/2017 - 09/2004
5	Autoimmune Diseases (Autoimmune Disease) 01/2014 - 05/2002
4	Systemic Vasculitis 10/2012 - 09/2004
3	Infections 01/2017 - 01/2011
3	Ankylosing Spondylitis 05/2011 - 09/2010
3	Systemic Scleroderma (Systemic Sclerosis) 01/2011 - 10/2007
3	Rheumatoid Arthritis 12/2010 - 05/2009
3	Necrosis 08/2010 - 11/2006
2	Glomerulonephritis 11/2014 - 01/2009
2	Atherosclerosis 10/2012 - 05/2008
2	Lupus Nephritis 08/2012 - 01/2002
2	Communicable Diseases (Infectious Diseases) 03/2011 - 01/2011
2	Sjogren's Syndrome (Sjogren Syndrome) 02/2009 - 06/2005
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2009 - 02/2008
1	Disease Progression 06/2015
1	Nephritis 11/2014
1	Proteinuria 11/2014
1	Ischemia 10/2012
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2012
1	Vascular Diseases (Vascular Disease) 10/2012
1	Stroke (Strokes) 10/2012
1	Acute Coronary Syndrome 10/2012
1	Atherosclerotic Plaque (Atheroma) 10/2012
1	Immune System Diseases (Immune Disorders) 08/2012
1	Bone Resorption 05/2011
1	Osteoporosis 05/2011
1	Metabolic Bone Diseases (Osteopenia) 05/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2010
1	Sarcoidosis (Schaumann Disease) 12/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2010
1	Serum Sickness 04/2010
1	Fatigue 04/2010
1	Acute Kidney Injury (Acute Renal Failure) 01/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2009

Drug/Important Bio-Agent (IBA)

20	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017 - 06/2002
9	AntibodiesIBA 01/2017 - 01/2002
9	Rituximab (Mabthera)FDA Link 06/2015 - 06/2005
9	AutoantibodiesIBA 01/2014 - 01/2002
7	Myeloblastin (Proteinase 3)IBA 01/2017 - 06/2002
4	HMGB1 Protein (HMG1)IBA 11/2014 - 08/2010
4	Peroxidase (Myeloperoxidase)IBA 01/2009 - 07/2002
3	Peptide Hydrolases (Proteases)FDA Link 06/2015 - 11/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013 - 01/2004
3	Azathioprine (Imuran)FDA LinkGeneric 09/2013 - 06/2006
3	VaccinesIBA 04/2011 - 01/2011
2	Prednisone (Sone)FDA LinkGeneric 06/2015 - 09/2013
2	Advanced Glycation End ProductsIBA 08/2012 - 01/2011
2	Receptor for Advanced Glycation End ProductsIBA 08/2012 - 08/2010
2	C-Reactive ProteinIBA 05/2011 - 07/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 08/2010
2	CytokinesIBA 12/2010 - 07/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2006 - 01/2004
2	anti-dsDNA autoantibodyIBA 01/2006 - 01/2002
2	Immunoglobulin G (IgG)IBA 01/2004 - 01/2002
2	AutoantigensIBA 07/2002 - 06/2002
1	Immunoglobulin M (IgM)IBA 01/2017
1	EnzymesIBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	GlucocorticoidsIBA 06/2015
1	CreatinineIBA 11/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2014
1	Biological ProductsIBA 01/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 10/2012
1	25-hydroxyvitamin DIBA 05/2011
1	Peptides (Polypeptides)IBA 05/2011
1	Collagen Type I (Type I Collagen)IBA 05/2011
1	ProcollagenIBA 05/2011
1	OsteocalcinIBA 05/2011
1	Biomarkers (Surrogate Marker)IBA 05/2011
1	Vitamin D FDA LinkGeneric 05/2011
1	Immunomodulating AgentsIBA 04/2011
1	Monoclonal AntibodiesIBA 12/2010
1	RadiopharmaceuticalsIBA 12/2010
1	Histones (Histone)IBA 08/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2010
1	ChromatinIBA 08/2010
1	LipopolysaccharidesIBA 08/2010
1	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2010
1	Rheumatoid FactorIBA 04/2010
1	SodiumIBA 11/2009
1	Transcription Factors (Transcription Factor)IBA 11/2009
1	Antinuclear AntibodiesIBA 06/2009
1	LigandsIBA 05/2009
1	Prostaglandins AIBA 01/2009
1	Methylprednisolone FDA LinkGeneric 01/2009
1	AntigensIBA 01/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2008
1	oxidized low density lipoproteinIBA 05/2008
1	Lipoprotein(a)IBA 05/2008

Therapy/Procedure

5	Therapeutics 09/2013 - 07/2006
2	Remission Induction 09/2013 - 06/2006
1	Retreatment 02/2009
1	Plasma Exchange 01/2009